BACKGROUND: Recent advances in high-throughput genotyping have made possible identification of genetic variants associated with increased risk of developing prostate cancer using genome-wide associations studies (GWAS).
However, the broader context in which the identified genetic variants operate is poorly understood. Here we present a comprehensive assessment, network, and pathway analysis of the emerging genetic susceptibility landscape of prostate cancer.
METHODS: We created a comprehensive catalog of genetic variants and associated genes by mining published reports and accompanying websites hosting supplementary data on GWAS. We then performed network and pathway analysis using single nucleotide polymorphism (SNP)-containing genes to identify gene regulatory networks and pathways enriched for genetic variants.
RESULTS: We identified multiple gene networks and pathways enriched for genetic variants including IGF-1, androgen biosynthesis and androgen signaling pathways, and the molecular mechanisms of cancer. The results provide putative functional bridges between GWAS findings and gene regulatory networks and biological pathways.
Written by:
Hicks C, Miele L, Koganti T, Vijayakumar S. Are you the author?
Cancer Institute, University of Mississippi Medical Center, Jackson, MS.; Department of Medicine, University of Mississippi Medical Center, Jackson, MS.; Department of Radiation Oncology, University of Mississippi Medical Center, Jackson, MS.
Reference: Cancer Inform. 2013 Aug 28;12:175-91.
doi: 10.4137/CIN.S12128
PubMed Abstract
PMID: 24031161
